Skip to main content
Clinical Data

Why HL7 v2 Still Wins for Clinical Data Exchange

FHIR gets the hype, but HL7 v2 still moves 95% of clinical data. Here's why you should build on v2, not FHIR, for core interoperability.

The Question: Is FHIR the Right Choice for Your Clinical Data Exchange?

95% of US healthcare organizations still use HL7 v2. That's not a typo. Every time you hear about FHIR, remember that number. FHIR is the shiny new toy, but v2 is the workhorse. If you're building a clinical data exchange, you need to know which one to pick. My answer? For most core interoperability needs, HL7 v2 is still the safer bet. FHIR has its place, but it's not the default.

Let's get one thing straight: I'm not anti-FHIR. FHIR is modern, developer-friendly, and great for mobile apps. But when it comes to moving high-volume clinical data between systems, v2 is the proven standard. The hype around FHIR often ignores the reality that v2 is deeply embedded in healthcare. If you're a health IT leader or developer, you need to make a choice. This article will give you a clear, no-nonsense answer.

What Exactly Are We Comparing?

HL7 v2 and FHIR are both standards for exchanging health information, but they're built for different worlds. v2 has been around since 1987 (HL7 International). It's a message-based standard that uses pipes and carets to separate fields. It's not pretty, but it's fast and reliable. FHIR, on the other hand, uses RESTful APIs and resources like Patient or Observation, exchanged in JSON or XML (HL7 International). It's designed for the web and for developers who want to query and update data independently.

Here's the key difference: v2 is optimized for high-throughput, legacy workflows. FHIR is optimized for developer-facing, mobile, and cloud-native applications (HL7 International). That's not a minor distinction. It affects how you design your systems, what skills you need, and how you handle data.

CriterionHL7 v2FHIR
AdoptionUsed by >95% of US healthcare organizations (HL7 International)Growing, but far less widespread
ArchitectureMessage-based, batch-orientedRESTful API, resource-based
Data formatPipe-delimited textJSON, XML, or RDF
StrengthsHigh-throughput, reliable, provenModern, flexible, easy for developers
WeaknessesHarder to learn, less flexibleLess mature, performance concerns at scale

If you're building a new system, you might be tempted to go with FHIR because it's modern. But consider this: when you need to send a lab result to every hospital in your state, v2 is what they use. You can't ignore that.

Why v2 Still Matters for Clinical Data

Let's talk about the real world. Healthcare systems are complex, and they don't replace their core infrastructure overnight. v2 is the common language of hospitals, labs, and payers. It's used for orders, results, admissions, and discharges. When a patient's lab result is sent from the lab to the EHR, that's v2. When a claim is submitted to an insurer, that's often v2. The sheer volume of v2 messages processed daily is staggering.

Now, FHIR is great for specific use cases. For example, if you're building a patient-facing app that needs to pull a patient's allergies, FHIR makes that easy. But for the bulk of clinical data exchange, v2 is the workhorse. It's not glamorous, but it gets the job done.

Let me give you a concrete example. Suppose you're a regional health information exchange (HIE) that connects 50 hospitals. You need to receive lab results from 20 different labs and route them to the right EHRs. Each lab sends thousands of messages a day. With v2, you have a mature, proven way to handle this. You have libraries and tools that parse v2 messages. You know it works. With FHIR, you'd be on the bleeding edge. You might have to write more custom code, and you'd have to worry about performance. That's not a risk you want to take in healthcare.

Also, don't forget the regulatory angle. HIPAA requires you to protect patient data. v2 was designed with that in mind. FHIR is newer, but it still has to comply with the same rules. The fact that v2 has been around longer means there are more resources for secure implementation.

So, my recommendation is this: if you're doing core clinical data exchange, start with v2. Use FHIR where it makes sense, but don't make it the backbone.

The Bottom Line: Don't Ditch v2 Yet

Here's what you need to remember: FHIR is not a replacement for v2. It's a complement. The fact that 95% of US healthcare organizations use v2 means it's not going away soon (HL7 International). If you're building a new integration, check if your partners support v2. They almost certainly do. If you're building a mobile app that needs to read a patient's lab results, FHIR might be better. But for the heavy lifting, v2 is the proven choice.

In the end, the best standard is the one that works. And v2 works. It's not sexy, but it's reliable. So, next time you hear someone say “FHIR is the future,” remember that v2 is the present. Build on the present, and add the future where it fits.

Sources

  • ONC / HHS (Health IT) - https://www.healthit.gov/topic/health-it-basics
  • HL7 International - https://www.hl7.org/fhir/

Share this article:

Comments (0)

No comments yet. Be the first to comment!